Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo

Cancer Letters

Volumn 333, Issue 2, 2013, Pages 244-252

  Rombouts, Krista ^a   Carloni, Vinicio ^a   Mello, Tommaso ^a,b   Omenetti, Sara ^a   Galastri, Sara ^a   Madiai, Stefania ^a   Galli, Andrea ^a,b   Pinzani, Massimo ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Clinical Pathophysiology ^*  (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Actin reorganization; Aurora B kinase AIM 1; Invasion migration; MARCKS; Syngeneic orthotopic murine model; Tumour stromal cells

Indexed keywords

AURORA B KINASE; MARCKS PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL CLONE; CELL MOTILITY; COLON CARCINOMA; COLON METASTASIS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FRAMESHIFT MUTATION; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER METASTASIS; LOSS OF FUNCTION MUTATION; METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; MITOSIS RATE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA INTERFERENCE; STELLATE CELL; STROMA CELL;

ACTINS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATIC STELLATE CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MITOSIS; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; STROMAL CELLS;

MURINAE; MUS;

EID: 84876739416     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.040     Document Type: Article

References (45)

1. Yamaguchi H., Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta 2007, 1773:642-652.
2. Dos Remedios C.G., Chhabra D., Kekic M., Dedova I.V., Tsubakihara M., Berry D.A., Nosworthy N.J. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol. Rev. 2003, 83:433-473.
3. Zhu Y., Dong Q., Tan B.J., Lim W.G., Zhou S., Duan W. The PKCalpha-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals. Cancer Res. 2005, 65:4520-4524.
4. Jin C.S., La M., Ahn J.K., Meadows G.G., Joe C.O. Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation. Biochem. Biophys. Res. Commun. 2001, 283:273-277.
5. Manenti S., Malecaze F., Chap H., Darbon J.M. Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation. Cancer Res. 1998, 58:1429-1434.
6. Jarboe J.S., Anderson J.C., Duarte C.W., Mehta T., Nowsheen S., Hicks P.H., Whitley A.C., Rohrbach T.D., McCubrey R.O., Chiu S., Burleson T.M., Bonner J.A., Gillespie G.Y., Yang E.S., Willey C.D. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma. Clin. Cancer Res. 2012, 18:3030-3041.
7. Micallef J., Taccone M., Mukherjee J., Croul S., Busby J., Moran M.F., Guha A. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Cancer Res. 2009, 69:7548-7556.
8. Techasen A., Loilome W., Namwat N., Takahashi E., Sugihara E., Puapairoj A., Miwa M., Saya H., Yongvanit P. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Cancer Sci. 2010, 101:658-665.
9. Kim N.G., Rhee H., Li L.S., Kim H., Lee J.S., Kim J.H., Kim N.K., Kim H. Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability. Oncogene 2002, 21:5081-5087.
10. Yamaguchi T., Iijima T., Mori T., Takahashi K., Matsumoto H., Miyamoto H., Hishima T., Miyaki M. Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancer. Dis. Colon Rectum 2006, 49:399-406.
11. Michel S., Kloor M., Singh S., Gdynia G., Roth W., von Knebel D.M., Schirmacher P., Blaker H. Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation. Mol. Carcinogenesis 2010, 49:175-182.
12. Hartwig J.H., Thelen M., Rosen A., Janmey P.A., Nairn A.C., Aderem A. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 1992, 356:618-622.
13. Wohnsland F., Schmitz A.A., Steinmetz M.O., Aebi U., Vergeres G. Interaction between actin and the effector peptide of MARCKS-related protein. Identification of functional amino acid segments. J. Biol. Chem. 2000, 275:20873-20879.
14. Tatsuka M., Katayama H., Ota T., Tanaka T., Odashima S., Suzuki F., Terada Y. Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 1998, 58:4811-4816.
15. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C., Chan C.S., Novotny M., Slamon D.J., Plowman G.D. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998, 17:3052-3065.
16. Ruchaud S., Carmena M., Earnshaw W.C. The chromosomal passenger complex: one for all and all for one. Cell 2007, 131:230-231.
17. Rombouts K., Mello T., Liotta F., Galli A., Caligiuri A., Annunziato F., Pinzani M. MARCKS actin-binding capacity mediates actin filament assembly during mitosis in human hepatic stellate cells. Am. J. Physiol. Cell Physiol. 2012, 303:C357-C367.
18. Pinzani M., Failli P., Ruocco C., Casini A., Milani S., Baldi E., Giotti A., Gentilini P. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J. Clin. Invest. 1992, 90:642-646.
19. Cassiman D., Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J. Hepatol. 2002, 37:527-535.
20. Mazzocca A., Coppari R., De F.R., Cho J.Y., Libermann T.A., Pinzani M., Toker A. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 2005, 65:4728-4738.
21. Yang Z.F., Poon R.T., To J., Ho D.W., Fan S.T. The potential role of hypoxia inducible factor 1 alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma. Cancer Res. 2004, 64:5496-5503.
22. Coulouarn C., Corlu A., Glaise D., Guenon I., Thorgeirsson S.S., Clement B. Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res. 2012, 72:2533-2542.
23. Rombouts K., Lottini B., Caligiuri A., Liotta F., Mello T., Carloni V., Marra F., Pinzani M. MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells. Exp. Cell Res. 2008, 314:1444-1454.
24. Verghese G.M., Johnson J.D., Vasulka C., Haupt D.M., Stumpo D.J., Blackshear P.J. Protein kinase C-mediated phosphorylation and calmodulin binding of recombinant myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein. J. Biol. Chem. 1994, 269:9361-9367.
25. Pinzani M., Gesualdo L., Sabbah G.M., Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J. Clin. Invest. 1989, 84:1786-1793.
26. Carney B.K., Caruso S., Cassimeris V.L. The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53. Cytoskeleton (Hoboken) 2012, 69:278-289.
27. Zhu X., Wang J., Moriguchi K., Liow L.T., Ahmed S., Kaverina I., Murata-Hori M. Proper regulation of Cdc42 activity is required for tight actin concentration at the equator during cytokinesis in adherent mammalian cells. Exp. Cell Res. 2011, 317:2384-2389.
28. Johnstone S.R., Best A.K., Wright C.S., Isakson B.E., Errington R.J., Martin P.E. Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function. J. Cell Biochem. 2010, 110:772-782.
29. Bai T., Luoh S.W. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation. Carcinogenesis 2008, 29:473-479.
30. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
31. Pinzani M., Macias-Barragan J. Update on the pathophysiology of liver fibrosis. Expert. Rev. Gastroenterol. Hepatol. 2010, 4:459-472.
32. Hernandez-Gea V., Friedman S.L. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011, 6:425-456.
33. Goldenberg N.M., Steinberg B.E. Surface charge: a key determinant of protein localization and function. Cancer Res. 2010, 70:1277-1280.
34. McLaughlin S., Aderem A. The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 1995, 20:272-276.
35. Laux T., Fukami K., Thelen M., Golub T., Frey D., Caroni P. GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J. Cell Biol. 2000, 149:1455-1472.
36. Herget T., Brooks S.F., Broad S., Rozengurt E. Expression of the major protein kinase C substrate, the acidic 80-kilodalton myristoylated alanine-rich C kinase substrate, increases sharply when Swiss 3T3 cells move out of cycle and enter G0. Proc. Natl. Acad. Sci. USA 1993, 90:2945-2949.
37. Reed J.C., Rapp U., Cuddy M.P. Transformed 3T3 cells have reduced levels and altered subcellular distribution of the major PKC substrate protein MARCKS. Cell Signal. 1991, 3:569-576.
38. Boucrot E., Kirchhausen T. Mammalian cells change volume during mitosis. PLoS One 2008, 3:e1477.
39. Carvalho A., Desai A., Oegema K. Structural memory in the contractile ring makes the duration of cytokinesis independent of cell size. Cell 2009, 137:926-937.
40. Steigemann P., Wurzenberger C., Schmitz M.H., Held M., Guizetti J., Maar S., Gerlich D.W. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 2009, 136:473-484.
41. Pritchard C.C., Grady W.M. Colorectal cancer molecular biology moves into clinical practice. Gut 2011, 60:116-129.
42. Guidoboni M., Gafa R., Viel A., Doglioni C., Russo A., Santini A., Del T.L., Macri E., Lanza G., Boiocchi M., Dolcetti R. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am. J. Pathol. 2001, 159:297-304.
43. Buckowitz A., Knaebel H.P., Benner A., Blaker H., Gebert J., Kienle P., von Knebel D.M., Kloor M. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br. J. Cancer 2005, 92:1746-1753.
44. You K.T., Li L.S., Kim N.G., Kang H.J., Koh K.H., Chwae Y.J., Kim K.M., Kim Y.K., Park S.M., Jang S.K., Kim H. Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors. PLoS Biol. 2007, 5:e109.
45. Speetjens F.M., Lauwen M.M., Franken K.L., Janssen-van Rhijn C.M., van D.S., Bres S.A., van de Velde C.J., Melief C.J., Kuppen P.J., van der Burg S.H., Morreau H., Offringa R. Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer. Int. J. Cancer 2008, 123:838-845.